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ABSTRACT We have developed a high-efficiency nucleic
acid delivery system that uses receptor-mediated endocytosis to
carry DNA macromolecules into cells. We accomplished this by
conjugating the iron-transport protein transferrin to polycat-
ions that bind nucleic acids. Human transferrin, as well as the
chicken homologue conalbumin, has been covalently linked to
the small DNA-binding protein protamine or to polylysines of
various sizes through a disulfide linkage. These modified
transferrin molecules maintain their ability to bind their cog-
nate receptor and to mediate efficient iron transport into the
cell. The transferrin-polycation molecules form electrophoret-
ically stable complexes with double-stranded DNA, single-
stranded DNA, and modified RNA molecules independent of
nucleic acid size (from short oligonucleotides to DNA of 21
kilobase pairs). When complexes of transferrin-polycation and
a bacterial plasmid DNA containing the gene for Photinus
pyralis luciferase are supplied to eukaryotic cells, high-level
expression of the luciferase gene occurs, demonstrating trans-
ferrin receptor-mediated endocytosis and expression of the
imported DNA. We refer to this delivery system as "transfer-
rinfection."
All actively metabolizing cells require iron that is taken up by
the cells as a transferrin-iron complex by means of receptor-
mediated endocytosis (the transferrin cycle; refs. 1-3). To
exploit this ubiquitous and efficient transport mechanism for
introducing DNA into cells, conjugates of chicken transferrin
(conalbumin) or human transferrin with DNA-binding poly-
cations were synthesized. We used protamine, a small,
naturally occurring, arginine-rich DNA-binding protein (4)
and synthetic polylysines of different degrees of polymeriza-
tion (-90, 270, or 450 L-lysine monomers). As target cells for
DNA delivery, avian erythroblasts transformed with condi-
tional erbB oncogenes (temperature sensitive v-erbB or c-
erbB with or without ligand) were selected because these
cells display a particularly active transferrin cycle when
induced to differentiate (5, 6). By using this system the
transferrin-polycation conjugates were shown to function as
high-efficiency iron transporters and as carriers to deliver a
gene to the living cell. Polylysine-asialoglycoprotein conju-
gates have been used similarly to target DNA to liver cells,
as reported by Wu and Wu (7, 8).
MATERIALS AND METHODS
Synthesis of Transferrin-Polycation Conjugates. Transfer-
rin was coupled to polylysine as described (9) by ligation
through disulfide bonds after modification with the bifunc-
tional reagent succinimidyl 3-(2-pyridyldithio)propionate
(SPDP; Pharmacia). The transferrin-protamine conjugates
were prepared in a similar manner, except that the less
reactive protamine (which lacks lysine amino groups) was
modified under nonaqueous conditions.
3-(2-Pyridyldithio)propionate-Modified Transferrin 1. A so-
lution of 120 mg (1.5 t&mol) of chicken transferrin (conalbu-
min, iron free; Sigma) in 3 ml of 100 mM sodium phosphate
buffer (pH 7.8) was subjected to gel filtration on a Sephadex
G-25 column. To the resulting 5-ml solution was added 200 ,ul
of 15 mM ethanolic solution of SPDP (3.0 Amol) and the
solution was vigorously mixed. After 1 hr at room tempera-
ture, purification by further Sephadex G-25 gel filtration
yielded 6 ml of a solution of 1.4 ,umol of transferrin modified
with 2.8 .mol ofdithiopyridine linker. Modification ofhuman
transferrin (iron-free; Sigma) was done identically.
3-Mercaptopropionate-Modified Polylysine 2. POIY(L-
lysine)s of different molecular weights were used-namely,
those with average chain length of 90, 270, or 450 lysine
monomers (pLys90, pLys270, or pLys450; hydrobromide; Sig-
ma). Both unlabeled and fluorescent-labeled polylysines
were used; fluorescent labeling with fluorescein isothiocya-
nate (Sigma) was performed in sodium bicarbonate buffer
(pH 9) for 3 hr. A gel-filtered solution of 1.1 pmol of pLys90(equivalent to 20 mg ofhydrobromide salt) in 1.2 ml of75 mM
sodium acetate buffer was brought to pH 8.5 by adding
sodium bicarbonate buffer. One hundred and eighty micro-
liters of a 15 mM ethanolic solution of SPDP (2.7 jAmol) was
added and then vigorously mixed. One hour later 200 iul of 1
M sodium acetate (pH 5) was added; after gel filtration with
20 mM sodium acetate, the solution contained 1.0 Amol of
pLys90 with 2.3 umol of dithiopyridine linker. Twenty-three
milligrams (150 tmol) of dithiothreitol in sodium bicarbonate
buffer was added, and the solution was kept under argon at
pH 7.5 for 1 hr; the pH was adjusted to 5.2 by adding sodium
acetate buffer, and after gel filtration (Sephadex G-25) a
solution of 0.97 umol of pLys90 modified with 2.2 /.mol of
mercaptopropionate linker (2.25 linkers for each pLys90
chain) was obtained. By the same procedure, modification of
0.33 gmol of pLys270 (equivalent to 19 mg of hydrobromide
salt) with 1.9 Amol of SPDP gave a 0.27-i&mol product of
pLys270 containing 1.3 umol of mercapto groups (4.8 linkers
for each pLys270 chain); modification of 0.20 umol of pLys45o
with 2.3 Amol of SPDP gave a 0.19-,umol product of pLys450
containing 2.1 gmol of mercapto groups (11 linkers for each
pLys450 chain).
Conjugation of Transferrin with Polylysine. Transferrin-
pLys270 conjugates were prepared by mixing 1.0 lAmol of
modified transferrin 1 in 100 mM phosphate buffer (pH 7.8)
with 0.14 1Lmol of modified pLys270 2 (in 20 mM sodium
acetate buffer) under argon. After 18 hr at room temperature
the reaction mixture was diluted with water to a volume of 10
ml and fractionated by cation-exchange chromatography
[Pharmacia Mono S column HR 10/10; gradient elution,
buffer A: 50 mM Hepes (pH 7.9) and buffer B: buffer A plus
Abbreviations: SPDP, N-succinimidyl-3-(2-pyridyldithio)propi-
onate; pLysqO, pLys270, and pLys450, polylysine of average chain
length of 90, 270, or 450 lysine monomers.
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3 M sodium chloride]. The excess of uncoupled transferrin
was eluted first; the product fractions were eluted during the
gradient between 30% and 50o buffer B and were pooled into
three conjugate fractions: transferrin-pLys270 A with a molar
ratio of transferrin to polylysine of 5.5:1, transferrin-pLys270
B with a ratio of 3.4:1, and transferrin-pLys270 C with a ratio
of 1.8:1. Conjugates were obtained in an overall yield of 0.23
timol of transferrin with 0.075 ,umol of pLys270. Transferrin-
pLysO conjugates were synthesized in an analogous way:
starting with 1.2 umol of transferrin 1 and 0.45 ,umol of
mercapto-modified pLys9O 2, conjugates transferrin-pLysgo
containing 0.32 limol of transferrin with 0.18 ,umol of pLys9O
were obtained. Transferrin-pLys450 conjugates were pre-
pared in a similar manner starting with 1.2 limol of transferrin
1 and 71 nmol of mercapto-modified pLys450 2. Purification of
the reaction mixture occurred by gel permeation chromatog-
raphy [see Fig. 2b; Pharmacia Superose 12 column; 1 M
guanidine chloride (pH 7.3)] and after dialysis (as described
below) yielded conjugate transferrin-pLys450 containing 0.40
limol of transferrin and 38 nmol of pLys450.
SDS/gel electrophoresis [10% SDS/8% polyacrylamide
(10), followed by Coomassie blue staining] of transferrin-
polylysine samples after pretreatment with 2-mercapto-
ethanol shows only transferrin bands, whereas in nonreduced
samples only more slowly migrating bands of the conjugates
are visible. All conjugates were dialyzed against a 20 mM
Hepes (pH 7.3) buffer containing 100 mM sodium chloride;
iron incorporation was performed by adding 6-12 ul of 100
mM iron citrate buffer (containing sodium bicarbonate,
adjusted to pH 7.8) for each mg of transferrin content [as
described (2, 11)].
3-Mercaptopropionate-Modified Protamine 2. To a solution
of 20 mg (3 ,umol) ofprotamine trifluoroacetate salt [prepared
by ion-exchange from salmon protamine (the same as sal-
mine) sulfate salt; Sigma] in 2 ml ofdimethyl sulfoxide and 0.4
ml of isopropanol containing 2.6 IlI (15 ,umol) of ethyldiiso-
propylamine, a solution of 30 ,mol of SPDP in 250 ul of
isopropanol and 250 ,ul of dimethyl sulfoxide was added in
several portions within 1 hr. After 3.5 hr at room tempera-
ture, the solution was evaporated in high vacuum and taken
up in 0.5% acetic acid/10% methanol. Gel filtration [Sepha-
dex G-10; 0.5% aqueous acetic acid/10% (vol/vol) methanol]
after Iyophilizing yielded 16 mg (2.5 ,umol) of protamine
acetate salt modified with 2.5 ,umol of dithiopyridine linker.
Reduction of 1.75 ,mol of protamine (containing 1.75 ,mol
of linker) with 16 mg of dithiothreitol in a sodium bicarbonate
buffer (pH 7.5) for 1 hr under argon, followed by pH
adjustment to 5.2 and gel filtration [Sephadex G-10, 20 mM
sodium acetate buffer (pH 5.2)] produced a solution of
protamine 2 modified with 1.6 ,umol of mercaptopropionate
linker.
Conjugation of Transferrin with Protamine. Reaction of the
protamine solution 2 described above (1.6 ,mol of linker)
with 1.35 ,umol of transferrin 1 (modified with 3.1 ,umol of
dithiopyridine linker) and purification by cation-exchange
chromatography (see Fig. 2a) as described for the transfer-
rin-polylysine conjugates gave four sequentially eluting
product fractions: transferrin-protamine A-D containing 90
nmol, 320 nmol, 240 nmol, or 120 nmol ofmodified transferrin
with increased amounts of protamine (as shown in the SDS
gel, see Fig. 3; 10% SDS/8% polyacrylamide, Coomassie
blue staining). Dialysis and iron incorporation was performed
as for the transferrin-polylysine conjugates.
Quantitative Assays. Polylysine content of fractions was
determined spectrophotometrically by ninhydrin assay or for
fluorescein isothiocyanate-labeled polylysine by absorption
at 495 nm. The amount of dithiopyridine linkers in modified
transferrin or polylysine was determined after reducing an
aliquot with dithiothreitol by measuring the absorption of
released pyridine-2-thione at 340 nm. The amount of free
mercapto groups was determined by using Ellman's reagent
(12) and measuring at 412 nm. Transferrin content offractions
was determined by UV measurement at 280 nm and correc-
tion (where necessary) of the value by subtracting the cor-
responding UV absorption of fluorescein isothiocyanate,
dithiopyridine, or buffer at 280 nm.
RESULTS
Synthesis of Transferrin-Polycation Conjugates. Transfer-
rin and protamine or polylysine were ligated by disulfide
bonds (Fig. 1 and Materials and Methods). First, dithiopy-
ridine groups were introduced into both apotransferrin and
protamine or polylysine by means of SPDP (9). For the less
reactive protamine, which contains no lysine amino groups,
modification of the trifluoroacetate salt in dimethyl sulfox-
ide/isopropanol quantitatively substituted one linker per
protamine molecule. The dithiopyridine groups in protamine
or polylysine were further reduced to give the free sulfhydryl
compounds 2 (Fig. 1 and Materials and Methods), which,
upon mixing with modified transferrin 1, reacted to give the
desired conjugates. After purification (Fig. 2), iron was
incorporated into all conjugates by adding iron citrate buffer
containing bicarbonate.
Dissociation of Transferrin-Polycation Conjugates. The di-
sulfide linkages of transferrin-polycation conjugates are sen-
sitive to reducing conditions. When samples are pretreated
with 2-mercaptoethanol, a transferrin band appears in an
analytical SDS gel (Fig. 3b) in all lanes after Coomassie blue
staining (the free protamine or polylysine moiety is not seen
because these positively charged groups do not migrate into
the gel). Without reduction of the disulfide bonds, the poly-
lysine conjugates do not fully enter the gel because of their
positive charge density and their high molecular weight and
are therefore partially lost upon staining (data not shown).
The protamine conjugates, having lower molecular weight,
show the expected, intermediate electrophoretic mobility
(Fig. 3a).
Formation of Complexes Between Transferrin-Polycation
Conjugates and DNA. Complexes of transferrin-polycation
with DNA were formed by mixing diluted solutions ofDNA
(30 ,g/ml or less) with the transferrin-polycation conjugates.
Dilution of the DNA and the use of phosphate-free buffer
(phosphates decrease solubility ofthe conjugates) were found
to be essential to prevent precipitation of the DNA com-











FIG. 1. Synthesis of transferrin (Tf)-polycation conjugates. The
polycation is poly(L-lysine) or salmon protamine.
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FIG. 2. Purification of transferrin (Tf)-polycation conjugates. (a)
Cation-exchange chromatography of transferrin-protamine (Tfprot)
conjugates. The excess of uncoupled transferrin elutes from the
column first; the conjugates are retained on the column due to their
positive charges but elute with a salt gradient (Tfprot fractions A-D
between 1 M to 2 M NaCl on a Mono S column). (b) Gel permeation
chromatography of the larger transferrin-pLys45M (TfpL) conjugates
(Superose 12 column; ---, fluorescence, 520 nm). AU, absorbance
units.
ological ionic conditions was confirmed by gel mobility-shift
assay using 32P-labeled A DNA cut with EcoRI/HindIII (Fig.
4). Furthermore, we find that the transferrin-polylysine and
transferrin-protamine conjugates associate avidly with DNA
and RNA oligonucleotides as short as 19 nucleotides as well
as with single-stranded DNA and elicit bandshifts similar to
those seen in Fig. 4 (unpublished results).
Transferrin-Polycations Function as Efficient Iron Trans-
porters in Differentiating Chicken Erythroblasts. Chicken
erythroblasts transformed with conditional erbB oncogenes
can be induced to differentiate into erythrocytes in vitro by
"switching off" oncogene function (5, 6). This in vitro
differentiation crucially depends on high levels of iron-
saturated transferrin (13) as well as on a highly active
transferring cycle (2) because inhibition of either arrests
differentiation, leading to cell disintegration (2, 13). Thus,
this cell system allowed us to assay whether the transferrin-
polylysine or transferrin-protamine conjugates and respec-
tive DNA complexes could functionally replace native iron
transferrin.
Epidermal growth factor receptor erythroblasts (H.B., un-
published results and ref. 6) were induced to differentiate by
removing epidermal growth factor and adding a partially
purified erythroid growth factor preparation devoid of trans-
a bF~~~~~~~~ ---i~~~~~~~~~~
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FIG. 3. SDS/gel electrophoresis of transferrin-protamine con-
jugates. (a) Transferrin (Tf) and transferrin-protamine A-D samples.
(b) Same samples but pretreated with 2-mercaptoethanol.
- 564 bp
FIG. 4. Gel shift of DNA with transferrin-polylysine (TfpL).
DNA binding of transferrin-polylysine was confirmed by gel mobil-
ity-shift assay with EcoRI/HindIII-cut A DNA fragments {between
21,221 and 564 base pairs (bp), 32P-labeled at the 3' end by filling in
the overlay with Klenow enzyme and [32P]dNTP}. To each sample
with 1 A.l (35 ng) of DNA, 3 Al of a 100 mM Hepes (pH 7.9) buffer
containing 1 M sodium chloride was added, and the samples were
mixed with increased amounts (10 ng-1000 ng of transferrin-
polylysine) of transferrin conjugates in 11 Aul of aqueous solution,
resulting in final sodium chloride concentration of 200 mM. Elec-
trophoresis on 1% agarose gel with 1 x TAE (40 mM Tris acetate/1
mM EDTA, pH 8) running buffer was done at 50 V (45 mA) for 2.5
hr; the gel was dried, and autoradiography proceeded for 2 hr at
-80°C with XAR film (Kodak).
ferrin (REV-factor, refs. 13 and 14). After incubation in
medium devoid of avian transferrin for 18 hr, different
amounts of iron-saturated transferrin or transferrin-
polycation conjugates were added to the cells (before or after
complexing them with plasmid DNA). After 1, 2, and 3 days,
cellular differentiation was determined by cytocentrifugation
and histochemical staining (5, 14) or by quantitative hemo-
globin assay (13). The results show that two different trans-
ferrin-polylysine conjugates (transferrin-pLysgo or transfer-
rin-pLys270) as well as the transferrin-protamine B conjugate
could functionally replace native transferrin in mediating
rapid iron transport into differentiating erythrocytes-their
specific activity being -1.5- to 2-fold lower (Fig. 5 and Table
1). Table 1 shows a comparable, low percentage of disinte-
grated cells, a high percentage of late reticulocytes and
erythrocytes, and high hemoglobin content with polycation
conjugates. Complexing DNA to transferrin-pLys270 and
transferrin-protamine did not grossly alter biological activity
of the conjugates (Table 1 and data not shown). When either
polylysine or protamine was mixed with an appropriate
amount of iron citrate and added to the cells instead of
transferrin conjugates, the cells failed to differentiate and
disintegrated, similar to the controls incubated without trans-
ferrin (data not shown). Taken together, both types of
transferrin-polycation conjugates were nearly as efficient in
mediating iron transport as was native transferrin, such
transport depending on the transferrin moiety of the respec-
tive complexes.
Transferrin-Polylysine and Transferrin-Protamine Conju-
gates Mediate Uptake of DNA into Cells and Expression of a
Luciferase Gene. Having shown that the various transferrin-
polylysine (transferrin-protamine) conjugates are still bio-
logically active in that they deliver iron to the cell, we next
tested whether the conjugates mediate uptake and expression
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FIG. 5. Erythroid differentiation mediated by transferrin-
polylysine (TfpL) conjugates. (A) Erythroblasts transformed by a
retrovirus containing the human epidermal growth factor receptor
together with a temperature sensitive v-myb oncogene were gener-
ated as described elsewhere. These cells were propagated at 37°C in
colony forming unit-E medium (15) with epidermal growth factor at
20 ng/ml. After two washes in colony forming unit-E medium, the
cells were seeded at 42°C into 14-mm dishes at 1 x 106 cells per ml
in 0.6 ml oftransferrin-free differentiation medium (16) supplemented
with insulin at 1,ug/ml and partially purified erythroid growth factor
(REV factor) at an optimum concentration (ref. 13; 1:5000 dilution for
the batch used) without additions (A), with iron-saturated transferrin
(o), or with iron-saturated transferrin-pLys270 conjugates (o, 100
,ug/ml each). After incubation as indicated, hemoglobin content was
measured photometrically in 100-,l aliquots (see ref. 13). (B) To
analyze erythroid differentiation as a function of transferrin (Tf) (or
transferrin-polylysine) concentration, cells were seeded as in A into
medium containing the indicated amounts of iron-saturated trans-
ferrin (o), transferrin-pLys9o (o), or transferrin-pLys270 (n) and
analyzed photometrically after 2 days. Hatched area in A and B,
hemoglobin content of transferrin-free controls (mean of four deter-
minations).
ofDNA into cells. An expression plasmid encoding the firefly
luciferase gene (17) was used as a reporter gene to monitor
efficient gene transfer and expression. The luciferase-
encoding plasmid DNA pRSVL was mixed with avian trans-
ferrin-polylysine (or transferrin-protamine) conjugates to
form the transferrin-polylysine-DNA (transferrin-prota-
mine-DNA) complexes, and the mixture was added to avian
HD-3 erythroblasts (5). After 24-hr incubation, cell extracts
were prepared and analyzed for luciferase enzyme activity.
Fig. 6 shows that the transferrin-polylysine conjugates, in-
deed, mediate uptake of luciferase-encoding plasmid DNA
because luciferase enzyme activity is detected in extracts
from these cells. Using a constant amount of DNA (3 ug of
pRSVL) and increased amounts of transferrin-polylysine
conjugates (1-30 ,g) in the complex formation reaction
increases the luciferase activity detected in the cells (Fig. 6).
The same result holds for transferrin-protamine conjugates
(18). We found that the efficiency of DNA import into cells
by means of the transferrin cycle was enhanced considerably
by treating human K-562 cells with agents affecting endoso-
mal/lysosomal pH, such as chloroquine (19). When this
modified procedure was applied to the K-562 cell system,
significant luciferase gene expression (0.9 x 106 light units of
3 ,ug ofplasmid DNA and 1.2 x 106 light units at 10 ,Ag ofDNA
per 3 x 105 cells) was seen in these cells (19).
DISCUSSION
We have presented protocols for the synthesis of covalent
conjugates of apotransferrin and two types of polycation
peptides, polylysine of various lengths or protamine (Fig. 1).
Typically, one pLysq0 moiety becomes linked to 2 transferrin
molecules; one pLys450 becomes linked to 10 transferrin
molecules (in general 1 transferrin per 50 lysines). One to
three protamine molecules link to one transferrin molecule.
The conjugates exhibited interesting properties when iron
was incorporated into the apotransferrin moiety. They were
recognized and transported by receptor-mediated endocyto-
sis in avian erythroblasts, although with somewhat reduced
affinity as compared with unmodified transferrin (18). Fur-
thermore, these conjugates were rapidly taken up into endo-
somal-like intracellular vesicles, as visualized by fluores-
cence microscopy (18). By using a more stringent bioassay
for the iron-transport protein-i.e., the ability to sustain
erythroid differentiation in vitro-which depends on a par-
ticularly efficient performance of the transferrin cycle (2, 13),
the conjugates exhibited 50-75% of the specific activity as
compared with native iron-transferrin complex. Thus, the
concatenation of several transferrin molecules with a single
polylysine chain followed by complex formation of several of
these conjugates with DNA to achieve approximate electro-
neutrality (see below) apparently did not impede their rec-
Table 1. Erythroid differentiation in response to medium additions
Medium addition Differentiation parameter
Transferrin- Cell no., Hemoglobin, Dead cells*, Mature Immature
Exp. Transferrin polylysine DNA x 106/ml E492 % cells*, % cells*, %
1 - 2.56 0.259 56 <1 44
+t 3.72 1.997 3 73 1
- Transferrin-pLysgot - 3.67 1.105 5 54 8
- Transferrin-pLyS270t 3.30 1.366 11 60 4
2 - pRSVLt 1.24 0.280 ND ND ND
+-§ pRSVL 5.22 2.459 ND ND ND
- Transferrin-pLys9o§ pRSVL 4.46 2.265 ND ND ND
3 - - 2.10 0.222 79 <1 21
+§ 2.55 1.369 6 72 0
- Transferrin-pLysgo§ 2.64 1.016 10 56 7
- Transferrin-protamine§ 2.76 1.055 9 72 4
Erythroid differentiation was monitored either by photometric hemoglobin assay (see Fig. 5, ref. 13), by counting in a Coulter counter, or
by cytocentrifugation followed by staining with neutral benzidine (ref. 14; to detect hemoglobin E492) plus histological dyes (Diff Quik; ref. 14).
ND, not done.
*Percentages of dead (disintegrated) cells, mature cells (late reticulocytes plus erythrocytes), and immature cells were determined as described(2, 14).
tFinal DNA concentration, 10,ug/ml.
fFinal concentration of transferrin and transferrin conjugates, 60 ;Lg/ml.§Final concentration of transferrin and transferrin conjugates, 100 Ag/ml.
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FIG. 6. Expression of luciferase gene in HD-3 cells after trans-
ferrin-polylysine (TfpL)-mediated gene transfer. For transferrin-
polylysine DNA complex formation 0-30 ,ug of transferrin-
polylysine conjugate in 250,ul of H20 was added to 3 ,ug of luciferase
encoding plasmid DNA (pRSVL, ref. 17) contained in 250 ,l of 0.3
M NaCl. This mixture was added to 107 HD-3 cells (5) growing in 10
ml of standard growth medium (EBM + H, ref. 5). Twenty-four hours
later cell extracts were prepared and analyzed for luciferase activity
(17). Bioluminescence was measured with the Clinilumat counter
(Berthold, Wildbach, F.R.G.). Transferrin-pLys9o (o), transferrin-
pLys270 A (A), transferrin-pLys270 B (n).
ognition and use by the transferrin receptor-mediated en-
docytosis machinery.
Because of its cationic properties, the transferrin-
polylysine (or transferrin-protamine) conjugate could bind
DNA avidly. As shown in the band-shift experiments of Fig.
4, the transferrin-polylysine conjugates yield a band shift
with both small and large EcoRI/HindIII restriction frag-
ments of A phage DNA without size discrimination. We
suspect that several conjugates are involved in complex
formation when interacting with long DNA molecules, thus
increasing the overall molecular weight of the complex. One
can calculate for the transferrin-pLys270 conjugate that a 3:1
mass ratio of conjugate to DNA approximately neutralizes
the nucleic acid negative charge by the positively charged
polylysine. Consistent with this calculation, nearly complete
mobility retardation of the DNA occurred at this ratio and
above; the optimum DNA transfection into avian erythro-
blasts (assayed by luciferase activity) also was obtained at
this ratio (see ref. 18).
In a single growing erythroblast, as many as 104 transferrin
molecules are taken up each minute by the >105 receptors
located at the cell surface (1). Ample evidence indicates that
transferrin receptor-mediated endocytosis is the mechanism
by which our transferrin-polylysine and transferrin-
protamine conjugates enter the cell (this paper; see also refs.
18 and 19). The capacity of the transferrin-polylysine or the
transferrin-protamine complexes (E.W., unpublished re-
sults) to bind and transport high-molecular weight DNA into
cells could be shown most clearly by using the circular
expression plasmid pRSVL (-7000 base pairs). We demon-
strated that the DNA transported into cells was expressed as
active luciferase enzyme (Fig. 6). With our preliminary
protocol, expression levels were still lower than those ob-
tained with DNA transfection into the same cells using a
DEAE-dextran transfection method optimized for avian
erythroblasts (18, 19); this is not too surprising because no
attempts have yet been made to increase release of ingested
DNA from endosomal vesicles in these cells. As will be
described (18, 19), use of agents affecting endosomal and
lysosomal pH (e.g., chloroquine) helps to increase the effi-
ciency of DNA uptake and expression.
In conclusion, we have developed a DNA transfection
protocol, transferrinfection, in which we subvert a natural
iron-uptake mechanism to transport DNA. The very same
transport system can be used to introduce oligonucleotides
into cells (unpublished results). We showed that at least a
portion of the pRSVL molecule reaches the cell nucleus,
where it can be expressed. In contrast to standard transfec-
tion protocols, which often cause appreciable cell death, we
found that transfection by means of transferrin-mediated
endocytosis is more physiological in nature, as no such cell
death is seen and erythroid differentiation proceeds normally
in the presence of the transferrin-polylysine complexes used
to import DNA into cells.
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